💬"The results of this study may help clinicians to determine that a patient is unlikely to achieve #remission or significant disease control after 6 months of #mepolizumab," Sarah Rhoads, MD, @DenPulm, said in a Healio Perspective.

Read more🔽
#remission #mepolizumab